»
»
»

Consensus des Analystes Sanofi

Cotation du 20/03/2019 à 11h04 Sanofi -0,11% 79,460€
  • SAN - FR0000120578
  • SRD
  • PEA
  •   PEA-PME
  • Consensus Renforcer
  • + Ajouter à : Mes portefeuilles | Mes Listes

Objectif de cours au 20/03/2019

86,078 €
Potentiel de +8%
cours actuel 79,460€

Note médiane des 24 analystes

2,0
5 Vendre 4 Alléger 3 Conserver 2 Renforcer 1 Acheter

Evolution des recommandations

Recommandations 20/03/2018 20/06/2018 20/09/2018 20/12/2018 20/03/2019
Acheter 7 6 9 10 10
Renforcer 3 4 5 4 5
Conserver 15 15 7 9 9
Alléger 1 1 1 1 -
Vendre 1 1 - - -
Nb d'analystes 27 27 22 24 24
Note Médiane 2,48 2,52 2,00 2,04 1,96
Historique des objectifs 81,182€ 77,296€ 81,918€ 84,683€ 86,078€

Prévisions

2018 2019 2020
Chiffre d'affaires 34 463,00 35 749,47 37 279,06
EBITDA 10 092,00 10 842,51 11 655,93
EBIT 8 884,00 9 350,30 10 036,92
Résultat Net 4 306,00 5 095,26 5 766,39
Flux de trésorerie disponible 3 570,00 6 920,59 7 126,34
Dette nette 17 715,00 14 134,63 12 367,30
PER 5,45 5,71 6,21
Copyright ©2019, S&P Global Market Intelligence. Reproduction of CIQ Estimates in any form is prohibited except with the prior written permission of S&P Global Market Intelligence. CIQ Estimates are not investment advice and a reference to a particular investment or security, a credit rating or any observation concerning a security or investment provided in CIQ Estimates is not a recommendation to buy, sell or hold such investment or security or make any other investment decisions. S&P Global Market Intelligence, its affiliates and their third-party providers (together, “S&P Global”) do not guarantee the accuracy, adequacy, completeness or availability of any information and are not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P GLOBAL DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P Global be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of CIQ Estimates.

Actualités Sanofi

Partenaires de Boursier.com